Parallel imaging has reduced acquisition time for contrast MR, making it possible to use 3D MR angiography in imaging infants with suspected congenital abnormalities.
Parallel imaging has reduced acquisition time for contrast MR, making it possible to use 3D MR angiography in imaging infants with suspected congenital abnormalities.
The new capability was demonstrated in a study of 22 infants and small children at the University of Heidelberg using time-resolved 3D FLASH MRA performed with GRAPPA using an acceleration factor of 2 on a 1.5T scanner. All studies were deemed diagnostic with no relevant motion artifacts, according to Dr. Joachim Eichorn. Small aberrant vessels including multiple aortopulmonary collateral arteries were visualized.
In related research, Dr. Jochem van den Berg at Sophia Children's Hospital in Rotterdam, the Netherlands, found perfusion imaging uncovers otherwise undetected ventricular diastolic dysfunctions including impaired relaxation and filling restrictions linked to the tetralogy of Fallot.
Dr. Giulia Russo at the University of Padua in Padova, Italy, described the value of delayed-enhancement MRI for assessing the risk of sudden death among 27 consecutive adults with repaired tetralogy of Fallot. Delayed enhancement was seen in seven of eight patients with histories of life-threatening arrhythmic events but only two of 19 without incidences of sustained ventricular tachycardia.
This special section was compiled by James Brice, senior editor of Diagnostic Imaging.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.